Allergen-mediated disease : keeping patients active
Gespeichert in:
| Deutscher übersetzter Titel: | Allergische Erkrankungen : Patienten aktiv halten |
|---|---|
| Autor: | O'Kane, John W.; Woodford, Ginger A. |
| Erschienen in: | The physician and sportsmedicine |
| Veröffentlicht: | 27 (1999), 9, S. 49-67, Lit. |
| Format: | Literatur (SPOLIT) |
| Publikationstyp: | Zeitschriftenartikel |
| Medienart: | Gedruckte Ressource Elektronische Ressource (online) |
| Sprache: | Englisch |
| ISSN: | 0091-3847, 2326-3660 |
| DOI: | 10.3810/psm.1999.09.981 |
| Schlagworte: | |
| Online Zugang: | |
| Erfassungsnummer: | PU199912407723 |
| Quelle: | BISp |
Abstract des Autors
A nasal corticosteroid is the most effective treatment for allergic rhinitis, but delayed improvement can reduce compliance. Topical vasoconstrictors, cromolyn, and NSAIDs are recommended for allergic conjunctivitis. Some athletes who have exercise-induced or exercise-exacerbated asthma may have a refractory period, which, along with short- and long-term beta-2 agonists, inhaled corticosteroids, and leukotriene antagonists, may be used to manage symptoms. Topical steroids are the main treatment for atopic dermatitis. Drug restrictions by sports governing bodies can limit therapies for competitive athletes. Verf.-Referat